UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The 2021 guidelines on the diagnosis of von Willebrand disease: A comparison with current clinical practice in Spanish centers

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-05, Vol.29 (3), p.925-927

2023

Volltextzugriff (PDF)

Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response

British journal of haematology, 2024-01, Vol.204 (1), p.315-323

2024

Volltextzugriff (PDF)

Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.106-115

2024

Volltextzugriff (PDF)

Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-01, Vol.26 (1), p.64-72

2020

Volltextzugriff (PDF)

Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect comparison method

European journal of haematology, 2023-11, Vol.111 (5), p.757-767

2023

Volltextzugriff (PDF)

Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.e772-e775

2021

Volltextzugriff (PDF)

A post hoc comparative real‐world analysis of HEAD‐US score for joint health assessment of patients with severe haemophilia A and B in Spain

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.513-522

2024

Volltextzugriff (PDF)

Platelet and immune characteristics of immune thrombocytopaenia patients non‐responsive to therapy reveal severe immune dysregulation

British journal of haematology, 2020-06, Vol.189 (5), p.943-953

2020

Volltextzugriff (PDF)

Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY)

Research and practice in thrombosis and haemostasis, 2022-11, Vol.6 (8), p.e12837, Article e12837

2022

Volltextzugriff (PDF)

Rapid and sustained immune tolerance to inhibitors induced by a plasma‐derived, VWF‐containing FVIII concentrate

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.e110-e113

2019

Volltextzugriff (PDF)

Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.479-487

2021

Volltextzugriff (PDF)

Procoagulant profile in patients with immune thrombocytopenia

British journal of haematology, 2016-12, Vol.175 (5), p.925-934

2016

Volltextzugriff (PDF)

The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus‐6B encephalitis after naïve T‐cell‐depleted allogeneic stem cell transplantation

Transfusion (Philadelphia, Pa.), 2021-05, Vol.61 (5), p.1505-1517

2021

Volltextzugriff (PDF)

Immune thrombocytopenia – in defence of the platelet count. Response to Hill

British journal of haematology, 2018-07, Vol.182 (1), p.130-131

2018

Volltextzugriff (PDF)

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

Research and practice in thrombosis and haemostasis, 2022-08, Vol.6 (6), p.e12782-n/a, Article e12782

2022

Volltextzugriff (PDF)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies

Journal of clinical medicine, 2020-10, Vol.9 (10), p.3297

2020

Volltextzugriff (PDF)

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia

Journal of clinical medicine, 2021-04, Vol.10 (8), p.1661

2021

Volltextzugriff (PDF)

International recommendations on the diagnosis and treatment of acquired hemophilia A

Haematologica (Roma), 2020-07, Vol.105 (7), p.1791-1801

2020

Volltextzugriff (PDF)

Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies

European journal of haematology, 2015-11, Vol.95 (S80), p.1-15

2015

Volltextzugriff (PDF)

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

Thrombosis and haemostasis, 2022-02, Vol.122 (2), p.295-299

2022

Volltextzugriff (PDF)

Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome

Journal of clinical medicine, 2022-05, Vol.11 (10), p.2721

2022

Volltextzugriff (PDF)

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

European journal of haematology, 2019-02, Vol.102 (2), p.111-122

2019

Volltextzugriff (PDF)

Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.519-530

2021

Volltextzugriff (PDF)

Managing Haemophilia for Life: 5th Haemophilia Global Summit

European journal of haematology, 2015-10, Vol.95 (S78), p.1-25

2015

Volltextzugriff (PDF)

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

European journal of haematology, 2016-05, Vol.96 (5), p.461-474

2016

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(296)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The 2021 guidelines on the diagnosis of von Willebrand disease: A comparison with current clinical practice in Spanish centers

Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response

Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry

Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial

Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect comparison method

Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies

A post hoc comparative real‐world analysis of HEAD‐US score for joint health assessment of patients with severe haemophilia A and B in Spain

Platelet and immune characteristics of immune thrombocytopaenia patients non‐responsive to therapy reveal severe immune dysregulation

Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY)

Rapid and sustained immune tolerance to inhibitors induced by a plasma‐derived, VWF‐containing FVIII concentrate

Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system

Procoagulant profile in patients with immune thrombocytopenia

The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus‐6B encephalitis after naïve T‐cell‐depleted allogeneic stem cell transplantation

Immune thrombocytopenia – in defence of the platelet count. Response to Hill

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia

International recommendations on the diagnosis and treatment of acquired hemophilia A

Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery

Managing Haemophilia for Life: 5th Haemophilia Global Summit

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

Suchergebnisse filtern